Quick Answer
XBiotech Inc. reported Net Income of -$45.54 million for fiscal year 2025.
XBiotech Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$45.54M | -18.2% |
| 2024 | -$38.53M | -56.9% |
| 2023 | -$24.56M | +25.4% |
| 2022 | -$32.90M | -88.9% |
| 2021 | -$17.41M | -55.2% |
| 2020 | -$11.22M | -101.7% |
| 2019 | $668.63M | +3263.2% |
| 2018 | -$21.14M | +36.2% |
| 2017 | -$33.15M | +37.2% |
| 2016 | -$52.76M | -40.8% |
| 2015 | -$37.48M | -72.5% |
| 2014 | -$21.72M | -118.8% |
| 2013 | -$9.93M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$6.01M | -19.8% | -242.1% |
| June 30, 2025 | -$1.76M | +86.5% | +83.9% |
| March 31, 2025 | -$10.88M | -8.8% | -117.0% |
| September 30, 2024 | -$5.01M | +31.9% | +61.4% |
| June 30, 2024 | -$13.01M | -48.8% | -30.0% |
| March 31, 2024 | -$10.00M | -162.1% | -35.8% |
| September 30, 2023 | -$7.36M | +41.8% | +15.8% |
| June 30, 2023 | -$8.74M | +24.9% | -129.1% |
- XBiotech Inc. showed a decrease of -18.2% in Net Income compared to the prior fiscal year.
- Over the 2013–2025 period, XBiotech Inc.’s net income has declined by 358.7% (from -$9.93 million to -$45.54 million).
- The most recent figure is from XBiotech Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 13, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: